A disappointing price for reducing its stake in Zhaopin couldn't obscure an excellent result for this employment classifieds group.
Another year, another poor result for Telstra. Yet there are signs better times lie ahead.
Australia's pre-eminent bank is faring better than first feared but it's already in the price
Ventilator sales have dried up but ResMed gained market share in CPAP devices.
The PCB design software provider has sold a non-core business.
An unwanted and under-priced bid gets lobbed at Infratil. Ignore it.